Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Ion Torrent, Stealthy Company Tied to Harvard’s George Church, Nabs $23M Venture Deal Luke Timmerman 11/06/09 Boston
Helixis, Caltech Spinoff With Desktop Genetic Analysis Tool, Nabs $7.3M Venture Financing Luke Timmerman 10/27/09 San Diego
Eastbourne Dumps Amylin Shares, Illumina Inks Licensing Deal, Avanir Releases Pseudobulbar Affect Data, & More San Diego Life Sciences News Denise Gellene 10/15/09 San Diego
Illumina Countersues Life Technologies Bruce V. Bigelow 10/14/09 San Diego
Illumina licenses Orchid Cellmark DNA technology Denise Gellene 10/13/09 San Diego
Sequenom Starts Over After Purge, Patent Lawsuits Flying Over Gene Sequencing Technologies, Zogenix Prepares for Needle-Free Injections, & More San Diego Biotech News Bruce V. Bigelow 10/01/09 San Diego
Life Tech and Illumina, Two San Diego Biotech Giants, in Patent Dispute Denise Gellene 09/24/09 San Diego
The San Diego Biotech Survival Index: Local Firms Make Strong Rebound In First Half of 2009 Luke Timmerman 09/23/09 San Diego
Helicos Biosciences, Running Low on Cash, Snaps Up $10M Lifeline Luke Timmerman 09/16/09 Boston
Canadian Consulate Helps San Diego’s Technology Companies Look Across the (Northern) Border—and Vice Versa Bruce V. Bigelow 09/11/09 San Diego
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News Rebecca Zacks 09/11/09 Boston
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News Luke Timmerman 09/03/09 Seattle
How to Build a Billion-Dollar Company (And Keep An Academic Day Job), According to David Walt Luke Timmerman 08/31/09 National
Can The Genome Be Cracked for $5,000? OVP, Enterprise Partners Say Yes in $45M Round Luke Timmerman 08/24/09 National
Clarus Leans on Customer Reviews at the Broad Institute to Bet on NanoString Luke Timmerman 07/29/09 Boston
Sequenom Discloses SEC Probe, How Evoke Pharma Got its Drug, Illumina Sales Fall Short, & More San Diego Life Sciences News Bruce V. Bigelow 07/02/09 San Diego
Illumina Sales Miss Expectations Luke Timmerman 07/01/09 San Diego
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News Luke Timmerman 06/18/09 Seattle
Trius Approaches Next Stage in Drug Development, China Partnerships a Hot Topic at CalAsia, Lpath Headed to Critical Juncture, & More San Diego Life Sciences News Bruce V. Bigelow 06/18/09 San Diego
CombiMatrix Reinvents Itself From Lab Toolmaker to Cancer Diagnostics Player Luke Timmerman 06/17/09 Seattle
NanoString Nabs $30M in Third Venture Round (Which It Hopes Will Be The Last) Luke Timmerman 06/09/09 Seattle
Seventh Sense Biosystems Developing Tech Akin to Check-Engine Light for the Body Ryan McBride 06/05/09 Boston
Novocell Snaps Up Second Stem Cell Patent, New CEO Pursues “Next Big Field” of Biotech Luke Timmerman 06/03/09 San Diego
To Build or Buy? Microsoft Amps Up Life Sciences Strategy By Buying Rosetta Biosoftware Luke Timmerman 06/02/09 Seattle
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use Luke Timmerman 05/27/09 Seattle
Novocell Hires John West as CEO Luke Timmerman 05/11/09 San Diego
Illumina Sues Affymetrix for Patent Infringement of Genetic Analysis Technology Juha-Pekka Tikka 05/05/09 San Diego
Life Technologies, Geospiza Form Cloud Computing Deal for Scientists to Dig Into Genome Luke Timmerman 04/28/09 Seattle
Microsoft Aims to Help Scientists Move Past Excel, Make Sense of Gene Data Overload Luke Timmerman 04/28/09 Seattle
Illumina Anticipates Purchasing Slowdown Juha-Pekka Tikka 04/22/09 San Diego
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.